The Valley Desk

ArticleClinical lung cancerPublished

Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase Inhibitors

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Clinical lung cancer
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Carboplatin; Antineoplastic Combined Chemotherapy Protocols; Protein Kinase Inhibitors; Aged; Middle Aged; Female; Male; Randomized Controlled Trials as Topic
PubMed ID
40545422
Added to directory
Source checked

Report a correction or request removal